Immune to Cancer: The CRI Blog
-
Rising Female Talents in Cancer Immunotherapy Research
In recent years, there has been a renewed and welcomed focus on female scientists in STEM (science,… -
ASCO 2023 Preview — Partnering with Patients: The Cornerstone of Cancer Care and Research
This weekend, the highly anticipated 2023 annual meeting of the American Society of Clinical Oncologists (ASCO) takes… -
<strong>Exploring the Future of Cancer Immunotherapy, with Dr. Nina Bhardwaj</strong>
The field of cancer immunotherapy has achieved great progress already in 2023. With each passing day, new… -
<strong><u>AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy</u></strong>
More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR… -
<strong>E. John Wherry, PhD, Receives 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology</strong>
E. John Wherry, PhD — the director of the Institute for Immunology, chair of the Department of… -
AACR 2023 Preview: Advancing the Frontiers of Cancer Science and Medicine
From April 14-19, the 2023 AACR annual meeting highlights a broad scope of immunotherapy breakthroughs, including cell… -
<strong>A Conversation with CRI ImmunoAdvocate Karen Peterson</strong>
Karen Peterson shares her journey from an immunotherapy clinical trial to patient advocate working to improve clinical… -
Love in the Lab: Valentine’s Day with the Doctors Delgoffe
CRI celebrates Valentine’s Day with immunologists Abby and Greg Delgoffe At first glance, one might not link… -
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm
In 2017, I was diagnosed with stage four triple-negative breast cancer (TNBC), one of the most aggressive…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.